BioSpace News Archive

CareCentrix, the leader in home-based and post-acute care (PAC) services, announced the renewal of its NCQA Utilization Management Accreditation

During these uncertain times, citizens have been searching for peace of mind. Normalcy has been found in COVID-19 antibody testing. Doctors and researchers are discovering that many Americans who have recovered from COVID-19 have the antibodies that could save others currently at risk or battling the virus.

AstraZeneca and Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced further positive results from the Phase III PROfound trial of LYNPARZA (olaparib) in men with metastatic castration-resistant prostate cancer (mCRPC) who have a homologous recombination repair gene mutation (HRRm) and have progressed on prior treatment with new hormonal agent (NHA) treatments (i.e., abiraterone or enzalutamide).

Enrollment Continues in Phase 3 RELIEF Study, with Interim Results of the First 50 Percent of Participants Expected in September 2020 Topline Results of Approximately 470 Participants with Fibromyalgia Expected in the First Quarter of 2021 NEW YORK, April 24, 2020 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced that 50 percent of the planned total number of participants have been ran

Sanofi (NASDAQ: SNY; EURONEXT: SAN) Experience the interactive Multichannel News Release here: https://www.multivu.com/players/English/8719551-sanofi-earnings-results-q1-2020/ Rapid and decisive response to COVID-19 global health crisis Sanofi showed resilience and maintained full business continuity worldwide including it

The patent now granted by the Japan Patent Office is valid until 2035. Diamyd Medical recently announced the grant of the corresponding patent in Europe . The patents primarily protect the administration method of Diamyd ® that is now being evaluated in the Phase IIb trial DIAGNODE-2 and which previously showed positive results in t

As VisiQuate Inc. continues to grow and expand into new areas of healthcare, the company today announced that Jim Lacy and Karl Robb, both of whom are widely known and highly respected figures in their industries, have joined its Board of Directors.

Forensic scientists now have access to the new ID NIMBUS Presto assay ready workstation, a rapid and easy-to-use automated DNA sample preparation system designed to extract nucleic acids from evidentiary crime scene samples.

Vela Diagnostics announced today that the manual version of the ViroKey™ SARS-CoV-2 RT-PCR Test has received the CE mark for in vitro diagnostic use. The test detects SARS-CoV-2 in patients suspected of COVID-19 by their healthc

Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), a clinical-stage company developing highly differentiated agents that target the underlying mechanisms of cancer, announced today that it has filed its proxy statement for the 2020 annual general meeting of shareholders. The annual general meeting of Aptose shareholders will be held on June 2, 2020 at 10:00 a.m. Pacific time in an online only format. There w